Here at ZAG/Sullivan, we are preparing for a fast-paced and prosperous 2020 alongside our distinguished clients from around the globe.
We are thankful to embark on another year with you - cheers to our future accomplishments in the new year AND BEYOND!
Clear Genetics - Acquired By Invitae Corp.
ZAG/Sullivan represented Clear Genetics, a leading developer of software for providing genetic services at scale, in its $50 million acquisition by Invitae Corporation (NYSE: NVTA), a leading medical genetics company. The acquisition will further expand Invitae's ability to scale and deliver genetic information as a part of routine medical care.
Clear Genetics' chatbot, named Gia, is an easy-to-use platform that guides patients throughout the genetic testing process and is currently being used by customers in Invitae's direct channel. Gia was developed in collaboration with genetic counselors to ensure information is offered in a medically responsible way. Gia can guide patients regarding consent, personalized risk assessment, insurance benefits, pre/post-test education and understanding their test results, all through an intuitive online conversation. Patients ask Gia questions throughout the process, and Gia uses natural language processing to respond with the resources they need.
Led by Scott Kaufman and Oded Har-Even, the ZAG/Sullivan team included David Guadagnoli, Amy Sheridan, Doug Stransky, Assaf Ariely, Patrick Driscoll, Roy Andersen, Howard Berkenblit, Corinne Hood Greene, David Kaplan, Jeff Karp, Eric Rietveld and Mitch Stein, along with the cooperation of Adv. Eliav Azulay Oz from Lglbiz.
Altus PCB - Acquired By NCAB Group
ZAG/Sullivan represented Altus PCB, a full-service supplier of printed circuit boards (PCBs) based in New Jersey, in its acquisition by NCAB Group, one of the world's largest suppliers of PCBs. The purchase price for Altus is SEK 37 million and an additional earn-out which in total will imply a multiple of 5-6 Ebita before potential synergies.
“We have been looking at Altus-PCB for some time and are delighted with this acquisition," said Hans Ståhl, President and CEO of NCAB Group. "It is a smaller acquisition but a great fit with NCAB. Our goal is to grow profitably, particularly in the USA, and Altus is especially interesting considering its operations in the high-tech area. We can see quite a number of synergies with NCAB. For example, we can provide Altus customers with access to many more factories in China and, as we have seen in the past, we can also apply our better delivery and payment conditions to their purchases.”
Led by Scott Kaufman and Amiti Rothstein, the ZAG/Sullivan team included Mitch Stein, Amy Sheridan, David Kaplan and Jeffrey Karp.
BiomX: From Ness-Ziona-Israel To New York!
Congratulations to our dear clients BiomX in becoming a public company and raising $60M in equity.
From PR Newswire:
"Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd."
Combined company renamed BiomX Inc. will trade on the NYSE American stock exchange under the symbol PHGE.
Adv.Shy Baranov and Adv.Adi Israel represented the company in the merger transaction with Chardan Healthcare Acquisition Corp., a special purpose acquisition company sponsored by affiliates of Chardan Capital Markets LLC.
IVC Research Center and ZAG/Sullivan Q3/2019 Israeli High-Tech Capital Raising Report
29.10.2019 | ZAG/Sullivan Press Release
Israeli High-Tech Companies Raised $2.24 Billion in 142 Deals in Q3/2019
Key facts:
- $2.24 billion raised in 142 deals—highest amount and number of deals in any quarter since 2013
- Amount raised in Q3 up 37% compared to $1.63 billion in Q3/2018
- 13 deals over $50m captured 57% of total capital raised in Q3/2019
- VC-backed deals raised $4.68 billion in Q1–Q3/2019 nearing $4.76 billion raised over 2018
- Tel Aviv, Israel. Israeli high-tech companies raised $2.24 billion in the third quarter of 2019, the highest quarterly amount since 2013. While the amount raised in Q3 kept pace with amounts raised in Q2/2019, deal numbers increased compared to the previous quarter (128 deals) and Q3/2018 (119 deals)
Full reports: globes.co.il | jpost.com | jdsupra.com
A.G.P. Consumer Cannabis Conference
In New York
October 2019
ZAG/Sullivan was proud to sponsor and participate at the "A.G.P Consumer Cannabis Conference" in New York, an exclusive event with 25 leading global companies in the CBD & Cannabis Industries. We hosted a wonderful cocktail event where Oded Har-Even spoke about our growing Cannabis practice in Israel and NY.
Sohn Investment Conference in Tel Aviv
November 2019
ZAG/Sullivan was proud to mark its fifth year participating in the Sohn Investment Conference in Tel Aviv. This dynamic event gathered investors, portfolio managers and asset allocators from around the globe to exchange ideas and expertise.
All proceeds from the conference are dedicated to the Israel Rett Syndrome Association “Silent Angels,” a non-profit that supports research to find a cure for girls with Rett Syndrome.
H.C Wainwright - 5th Annual Conference
In Tel Aviv
November 2019
ZAG/Sullivan was proud to sponsor and participate at the HCW 5th annual conference in Tel Aviv-Israel, 10 November 2019 at the Hilton Tel-Aviv. It was a pleasure seeing our clients from around the globe, leading biomed companies and partners.
Between Privacy & Wellness:
A GDPR Workshop
November 2019
Adv. Tamir Chagal (pictured below, standing), a partner at the firm’s High-Tech department and head of the privacy and GDPR practice at our Tel Aviv office, shared his experience and knowledge in a hands on the workshop: “Between Privacy & Wellness” to Welltech1’s startups.
The workshop discussed the framework and goal of GDPR, its impact of how information will be used and stored, and its unique impact on startups in the wellness-tech field.
IAC Florida
December 2019
Oded Har-Even, ZAG/Sullivan`s Partner and Managing Director (pictured below on stage, left), was a moderator at the Israeli-American Council National Summit in Miami, a weekend-long Conference with nearly 4,000 attendees. Oded led a conversation entitled "Envisioning the Future of Work and Education" and shared ZAG/Sullivan’s guiding principles of entrepreneurship and innovation, along with notable speakers such as: President of Tel Aviv University Professor Ariel Porat, and CEOs of Biomed companies.
MJBizCon Conference Las Vegas
December 2019
ZAG/Sullivan was proud to host a cocktail evening during the MJBizCon week, the largest cannabis industry conference in the world. Together with our partners, Alliance Global Partners (A.G.P.), the ZAG/Sullivan team brought together over 120 entrepreneurs, investors and companies to network with one another and catch up on new developments in this evolving and expanding industry. The quickly growing field of medical cannabis requires deft legal strategy, and ZAG/Sullivan remains at the forefront for our client’s needs.
Join Us At Our Cocktail Reception At JP Morgan Conference In San Francisco
Hosted by ZAG/Sullivan in collaboration with our partners at Oppenheimer Healthcare. We hope to see you there on January 14th, 2020.
Stay Tuned!
New Nasdaq Initial Listing Criteria in Effect as of August 2019
The Securities and Exchange Commission has recently approved Nasdaq Stock Market LLC’s (Nasdaq) proposal to revise Nasdaq’s initial listing application standards to improve liquidity in the market.
Read more: ZAG/Sullivan Client Alert (26 September 2019)
Please Meet Ilana Neck Levin, Our New Associate In New York!
Ilana joined the Corporate Department recently. She received her LL.B. from Haifa University in Israel in 2014, and her LL.M from Harvard Law School in 2018. While in law school, where she ranked first in her class, Ilana received several honors for academic achievement and social contributions, including: Rector's Prize for Outstanding Students; Haifa University Memorial Award; Human Rights Memorial Award; and Dean's Honor List. Ilana's practice focuses on representing corporations, private equity firms, investment funds and major financial institutions in a broad range of commercial financing transactions, including leveraged cash-flow and asset-based credit facilities and asset securitizations.